You are here: Home » Topics » » Cancer » Videos

Roche breast cancer drug "unprecedented" in extending lives

Sep 29, 2014    

MADRID (Reuters) A new breast cancer drug from Roche has shown "unprecedented" benefits in extending lives in a clinical trial and experts urged its widespread use for women with an aggressive form of the disease.Patients with a type of breast cancer known as HER2 positive, which makes up about a quarter of all breast cancers, who were given Perjeta on top of older medicine Herceptin and chemotherapy lived 15.7 months longer than those on Herceptin and chemotherapy alone.That is the longest extension to survival ever seen for a drug studied in metastatic breast cancer and also an un...

Read More